# Gilead Sciences, Inc.: Form 4, filed Jun 30, 2023

- Company: [Gilead Sciences, Inc.](/companies/gild.md) (CIK 882095)
- Form: 4
- Filed: 2023-06-30
- Accepted by EDGAR: Jun 30, 2023, 15:12 ET
- Period: 2023-06-28
- Accession: 0001104659-23-077015
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/882095/000110465923077015/xslF345X04/tm2320354-1_4seq1.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/882095/000110465923077015/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/882095/000110465923077015/xslF345X04/tm2320354-1_4seq1.xml

Filed Jun 30, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-077015. Last ingested by Listed: Nov 4, 2026, 17:49 ET. No prices; not investment advice.